AI Helps Diagnose Post-COVID Lung Problems

A new computer-aided diagnostic tool developed by KAUST (King Abdullah University of Science & Technologym, Saudi Arabia) scientists could help overcome some of the challenges of monitoring lung health following viral infection.

Like other respiratory illnesses, COVID-19 can cause lasting harm to the lungs, but doctors have struggled to visualize this damage. Conventional chest scans do not reliably detect signs of lung scarring and other pulmonary abnormalities, which makes it difficult to track the health and recovery of people with persistent breathing problems and other post-COVID complications.

The new method developed by KAUST - known as Deep-Lung Parenchyma-Enhancing (DLPE) - overlays artificial intelligence algorithms on top of standard chest imaging data to reveal otherwise indiscernible visual features indicative of lung dysfunction.

Through DLPE augmentation, "radiologists can discover and analyze novel sub-visual lung lesions," says computer scientist and computational biologist Xin Gao. "Analysis of these lesions could then help explain patients’ respiratory symptoms," allowing for better disease management and treatment, he adds.

Gao and members of his Structural and Functional Bioinformatics Group and the Computational Bioscience Research Center created the tool, along with artificial intelligence researcher and current KAUST Provost Lawrence Carin and clinical collaborators from Harbin Medical University in China.

The method first eliminates any anatomical features not associated with the lung parenchyma; the tissues involved in gas exchange serve as the main sites of COVID-19 - induced damage. That means removing airways and blood vessels, and then enhancing the pictures of what is left behind to expose lesions that might be missed without the computer's help.

The researchers trained and validated their algorithms using computed tomography (CT) chest scans from thousands of people hospitalized with COVID-19 in China. They refined the method with input from expert radiologists and then applied DLPE in a prospective fashion for dozens of COVID-19 survivors with lung problems, all of whom had experienced severe disease requiring intensive care treatment.

In this way, Gao and his colleagues demonstrated that the tool could reveal signs of pulmonary fibrosis in COVID long-haulers, thus helping to account for shortness of breath, coughing and other lung troubles. A diagnosis, he suggests, that would be impossible with standard CT image analytics.

"With DLPE, for the first time, we proved that long-term CT lesions can explain such symptoms," he says. "Thus, treatments for fibrosis may be very effective at addressing the long-term respiratory complications of COVID-19."

Although the KAUST team developed DLPE primarily with post-COVID recovery in mind, they also tested the platform on chest scans taken from people with various other lung problems, including pneumonia, tuberculosis and lung cancer. The researchers showed how their tool could serve as a broad diagnostic aide for all lung diseases, empowering radiologists to, as Gao puts it, "see the unseen."

Zhou L, Meng X, Huang Y et al.
An interpretable deep learning workflow for discovering subvisual abnormalities in CT scans of COVID-19 inpatients and survivors.
Nat Mach Intell, 2022. doi: 10.1038/s42256-022-00483-7

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...